As policymakers continue to discuss healthcare legislation, the AHA has developed several new resources to help hospitals and other stakeholders understand the proposals and their potential impact. These include a summary of current congressional price transparency activity and AHA recommendations, as well as a detailed side-by-side comparison of House and Senate price transparency bills.

The AHA also has released a comprehensive side-by-side comparison of three 340B reform proposals under consideration in Congress, including the 340B for Patients Act, the SECURE 340B Act and the SUSTAIN 340B Act. The resource outlines how each proposal would address critical issues such as patient definition, contract pharmacies, transparency requirements, rebate models and program oversight.

Headline
The U.S. District Court for the District of Maine should deny motions by several drug companies and Pharmaceutical Research and Manufacturers of America to…
Headline
The AHA today voiced support () for the 340B Rebate Model Delay Act (H.R. 10770)in a letter to the bill’s House sponsors. The bipartisan bill would pause the…
Headline
The AHA, the Maine Hospital Association and four safety-net hospitals Oct. 9 filed a lawsuit in the U.S. District Court for the District of Maine challenging…
Headline
The AHA, the New Hampshire Hospital Association and 340B Health have filed an amicus brief supporting Mary Hitchcock Memorial Hospital’s request for a…
Headline
The Department of Health and Human Services’ Health Resources and Services Administration Oct. 1 announced approval of 10 drug companies to participate in the…
Headline
The Centers for Medicare & Medicaid Services’ 340B Part D claims data repository became available Oct. 1 for voluntary data submissions. While data…